Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Fernandez Becerra, Carmen ^a   Sanz, Sergi ^a   Brucet, Marina ^a   Stanisic, Danielle I ^b,c   Alves, Fabiana P ^d   Camargo, Erney P ^d   Alonso, Pedro L ^a   Mueller, Ivo ^b   Del Portillo, Hernando A ^a,e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTISERUM; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE FUSION PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; MALARIA VACCINE; PLASMODIUM VIVAX MEROZOITE SURFACE PROTEIN 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; MEROZOITE SURFACE PROTEIN 1; PROTOZOON ANTIBODY;

ACTIVE IMMUNIZATION; ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BIOPLEX ASSAY; BLOOD SAMPLING; BRAZIL; CARBOXY TERMINAL SEQUENCE; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS COUPLING REACTION; ENDEMIC DISEASE; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MOLECULE; MULTIPLEX POLYMERASE CHAIN REACTION; PAPUA NEW GUINEA; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROLOGY; ANIMAL; ANTIBODY PRODUCTION; BLOOD; CLASSIFICATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; VALIDATION STUDY;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; BRAZIL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOGLOBULIN G; MALARIA, VIVAX; MEROZOITE SURFACE PROTEIN 1; PAPUA NEW GUINEA; PLASMODIUM VIVAX; RECOMBINANT PROTEINS;

EID: 77649291941     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-29     Document Type: Article

References (23)

1. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. I Mueller MR Galinski JK Baird JM Carlton DK Kochar PL Alonso HA del Portillo, Lancet Infect Dis 2009 9 555 566 10.1016/S1473-3099(09)70177-X 19695492
2. Characterization of naturally acquired human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax. G Levitus F Mertens MA Speranca LM Camargo MU Ferreira HA del Portillo, Am J Trop Med Hyg 1994 51 68 76 8059917
3. Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein. J Xainli JL Cole-Tobian M Baisor W Kastens M Bockarie SS Yazdani CE Chitnis JH Adams CL King, Infect Immun 2003 71 2508 2515 10.1128/IAI.71.5.2508- 2515.2003 12704122
4. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population. TM Tran J Oliveira-Ferreira A Moreno F Santos SS Yazdani CE Chitnis JD Altman EV Meyer JW Barnwell MR Galinski, Am J Trop Med Hyg 2005 73 244 255 16103583
5. Immune responses to Plasmodium vivax pre-erythrocytic stage antigens in naturally exposed Duffy-negative humans: a potential model for identification of liver-stage antigens. R Wang M Arevalo-Herrera MJ Gardner A Bonelo JM Carlton A Gomez O Vera L Soto J Vergara SL Bidwell A Domingo CM Fraser S Herrera, Eur J Immunol 2005 35 1859 1868 10.1002/eji.200425807 15864779
6. Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax. MB Barbedo R Ricci MC Jimenez MG Cunha SS Yazdani CE Chitnis MM Rodrigues IS Soares, Mem Inst Oswaldo 2007 102 335 339
7. A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1. PA Nogueira FP Alves C Fernandez-Becerra O Pein NR Santos LH Pereira da Silva EP Camargo HA del Portillo, Infect Immun 2006 74 2726 2733 10.1128/IAI.74.5.2726-2733.2006 16622209
8. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. CL King P Michon AR Shakri A Marcotty D Stanisic PA Zimmerman JL Cole-Tobian I Mueller CE Chitnis, Proc Natl Acad Sci USA 2008 105 8363 8368 10.1073/pnas.0800371105 18523022
9. Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. B Guilbert G Dighiero S Avrameas, J Immunol 1982 128 2779 2787 6176652
10. A novel monoclonal antibody screening method using the Luminex-100 microsphere system. J Seideman D Peritt, J Immunol Methods 2002 267 165 171 10.1016/S0022-1759(02)00168-0 12165438
11. Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens. GG Fouda RF Leke C Long P Druilhe A Zhou DW Taylor AH Johnson, Clin Vaccine Immunol 2006 13 1307 1313 10.1128/CVI.00183-06 17035513
12. A semi-automated multiplex high-throughput assay for measuring IgG antibodies against Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasma. GK Cham J Kurtis J Lusingu TG Theander AT Jensen L Turner, Malar J 2008 7 108 10.1186/1475-2875-7-108 18549480
13. High throughput functional assays of the variant antigen PfEMP1 reveal a single domain in the 3D7 Plasmodium falciparum genome that binds ICAM1 with high affinity and is targeted by naturally acquired neutralizing antibodies. AV Oleinikov E Amos IT Frye E Rossnagle TK Mutabingwa M Fried PE Duffy, PLoS Pathog 2009 5 1000386 10.1371/journal.ppat.1000386 19381252
14. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. FP Alves RR Durlacher MJ Menezes H Krieger LH Silva EP Camargo, Am J Trop Med Hyg 2002 66 641 648 12224567
15. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. IS Soares G Levitus JM Souza HA Del Portillo MM Rodrigues, Infect Immun 1997 65 1606 1614 9125537
16. A general methodology for the analysis of experiments with repeated measurement of categorical data. GG Koch JR Landis JL Freeman DH Freeman Jr RC Lehnen, Biometrics 1977 33 133 158 10.2307/2529309 843570
17. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins. RE Biagini DL Sammons JP Smith BA MacKenzie CA Striley V Semenova E Steward-Clark K Stamey AE Freeman CP Quinn JE Snawder, Clin Diagn Lab Immunol 2004 11 50 55 14715544
18. Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1. IS Soares MG da Cunha MN Silva JM Souza HA Del Portillo MM Rodrigues, Am J Trop Med Hyg 1999 60 357 363 10466961
19. IgG isotype to C-terminal 19 kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil. CG Morais IS Soares LH Carvalho CJ Fontes AU Krettli EM Braga, Parasitol Res 2005 95 420 426 10.1007/s00436-005-1314-x 15759156
20. Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax. KJ Lim JW Park JS Yeom YH Lee SB Yoo JH Oh MJ Sohn YY Bahk YS Kim, Parasitol Res 2004 92 384 389 10.1007/s00436-003-1009-0 14745545
21. Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon. FP Alves LH Gil MT Marrelli PE Ribolla EP Camargo LH Da Silva, J Med Entomol 2005 42 777 779 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2 16363160
22. The risk of malarial infections and disease in Papua New Guinean children. P Michon JL Cole-Tobian E Dabod S Schoepflin J Igu M Susapu N Tarongka PA Zimmerman JC Reeder JG Beeson L Schofield CL King I Mueller, Am J Trop Med Hyg 2007 76 997 1008 17556601
23. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka. T Wickramarachchi RJ Illeperuma L Perera S Bandara I Holm S Longacre SM Handunnetti PV Udagama-Randeniya, Int J Parasitol 2007 37 199 208 10.1016/j.ijpara.2006.09.002 17055511